Clinical Trial Update: Thymic Tolerance in Pediatric Heart Transplantation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating thymic tolerance in pediatric heart transplantation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplantation

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Heart Transplantation | Phase 2 | Status: TERMINATED